Teenretrovirale middel: Verskil tussen weergawes
Content deleted Content added
No edit summary |
k spel efavirenz→efavirens |
||
Lyn 17:
| "Truvada" || [[tenofovir]]/[[emtrisitabien]] || 2 Augustus 2004 || Gilead Sciences
|-
| "Atripla" || [[Emtrisitabien/tenofovir/
|-
| "Complera" || rilpivirien + [[tenofovir]]/[[emtrisitabien]] || 10 Augustus 2011 || Gilead Sciences en <br />Tibotec (Johnson & Johnson)
Lyn 25:
In Augustus 2012 is die verkose eerste-linie terapie in die [[VSA]]:
* [[tenofovir]]/[[emtrisitabien]] ('n kombinasie van twee [[nukleosied analoog trutranskriptase remmer|NRTIs]]) en [[
* tenofovir/emtrisitabien en raltegravir
* tenofovir/emtrisitabien, [[ritonavir]], en darunavir (die laaste twee is protease-ensiemremmers)
|